Aroa Biosurgery (ASX:ARX) Ending Cash Position : A$10.57 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Aroa Biosurgery Ending Cash Position?

Aroa Biosurgery's Ending Cash Position for the quarter that ended in Mar. 2024 was A$10.57 Mil.

Aroa Biosurgery's quarterly Ending Cash Position declined from Mar. 2023 (A$8.93 Mil) to Sep. 2023 (A$3.68 Mil) but then increased from Sep. 2023 (A$3.68 Mil) to Mar. 2024 (A$10.57 Mil).

Aroa Biosurgery's annual Ending Cash Position increased from Mar. 2022 (A$5.73 Mil) to Mar. 2023 (A$8.93 Mil) and increased from Mar. 2023 (A$8.93 Mil) to Mar. 2024 (A$10.57 Mil).

Aroa Biosurgery Ending Cash Position Historical Data

The historical data trend for Aroa Biosurgery's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aroa Biosurgery Ending Cash Position Chart

Aroa Biosurgery Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Ending Cash Position

14.12

5.73

8.93

10.57

Aroa Biosurgery Semi-Annual Data
	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Ending Cash Position	Get a 7-Day Free Trial			5.73	10.55	8.93	3.68	10.57

Aroa Biosurgery Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Aroa Biosurgery's Ending Cash Position for the fiscal year that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	8.752	+	1.818
	=	10.57

Aroa Biosurgery's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	3.563	+	7.007
	=	10.57

Aroa Biosurgery Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Aroa Biosurgery's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Aroa Biosurgery (ASX:ARX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aroa Biosurgery Ltd (ASX:ARX) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

64 Richard Pearse Drive, Mangere, Airport Oaks, Auckland, NZL, 2022

Website

https://www.aroabio.com

Aroa Biosurgery Ltd is a soft tissue regeneration company which develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery.

Aroa Biosurgery (ASX:ARX) Headlines

No Headlines